Article info

Download PDFPDF

Response to: Cryoglobulinemic vasculitis in the era of direct-acting antiviral drug
Free

Authors

  • David Saadoun Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, France INSERM, UMR_S 959, Paris, France CNRS, FRE3632, Paris, France Department of Internal Medicine and Clinical Immunology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France PubMed articlesGoogle scholar articles
  • Patrice Cacoub Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, France INSERM, UMR_S 959, Paris, France CNRS, FRE3632, Paris, France Department of Internal Medicine and Clinical Immunology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr David Saadoun, Département de Médecine Interne et d'Immunologie clinique, Groupe Hospitalier Pitié-Salpêtrière, 84 Boulevard de l'Hôpital, Paris 75013, France; david.saadoun{at}aphp.fr
View Full Text

Citation

Saadoun D, Cacoub P
Response to: Cryoglobulinemic vasculitis in the era of direct-acting antiviral drug

Publication history

  • Received October 19, 2016
  • Accepted October 20, 2016
  • First published November 14, 2016.
Online issue publication 
February 17, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.